Risk factors for new-onset diabetes mellitus after kidney transplantation (NODAT): a Brazilian single center study
Autor: | Thelma L. Skare, Camila Ferreira Lima, Renato Nisihara, Paulo Jaworski, Amanda Grden |
---|---|
Jazyk: | angličtina |
Předmět: |
Adult
Male medicine.medical_specialty Endocrinology Diabetes and Metabolism 030232 urology & nephrology lcsh:Medicine 030230 surgery Single Center lcsh:Diseases of the endocrine glands. Clinical endocrinology Statistics Nonparametric Tacrolimus 03 medical and health sciences Postoperative Complications 0302 clinical medicine Risk Factors Internal medicine Diabetes mellitus renal transplant medicine Humans Kidney transplantation Dyslipidemias Retrospective Studies Univariate analysis lcsh:RC648-665 business.industry Incidence Incidence (epidemiology) New-onset diabetes after transplantation (NODAT) lcsh:R Retrospective cohort study Middle Aged medicine.disease Kidney Transplantation calcineurin inhibitors Logistic Models Hypertension diabetes mellitus Female business Body mass index Brazil Immunosuppressive Agents Dyslipidemia |
Zdroj: | Archives of Endocrinology and Metabolism, Vol 62, Iss 6, Pp 597-601 Archives of Endocrinology and Metabolism v.62 n.6 2018 Arquivos de Endocrinologia e Metabolismo Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) instacron:SBEM |
ISSN: | 2359-4292 |
Popis: | Objectives: This study aims to verify the new-onset diabetes after kidney transplant (NODAT) incidence in recipients within 1 year after kidney transplantation from a single center in Southern Brazil and to assess the associated conditions. Subjects and methods: A retrospective study of 258 post-renal transplant patients was performed. Demographic (gender, age, ethnic background) and clinical (origin of graft, associated infections, body mass index (BMI) at transplant time and 6 and 12 months after, causes of renal failure, and comorbidities) data were analyzed. All patients were on tacrolimus, mycophenolate mofetil, and prednisone treatment. Patients with and without NODAT were compared. Results: A NODAT incidence of 31.2% was noted 1 year post transplantation. In the univariate analysis, patients with NODAT were older (p = 0.001), mostly had African–American ethnic background (p = 0.02), and had renal failure secondary to high blood pressure (HBP) (p = 0.001). The group of patients with NODAT also had more incidence of post-transplant HBP (p = 0.01), heart failure (p = 0.02), and dyslipidemia (p = 0.001). Logistic regression showed that African–American ethnic background, post-transplant HBP, and dyslipidemia were independently associated with NODAT. Conclusion: This study shows a NODAT incidence that is greater in patients with African–American ethnic background and that is associated with HBP and dyslipidemia. |
Databáze: | OpenAIRE |
Externí odkaz: |